|
Market Closed -
NYSE
06:10:00 11/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.4780 USD | -2.83% |
|
-0.62% | -64.59% |
| Market Cap | 5.36M 4.61M 4.35M 3.96M 7.4M 512M 7.47M 51.76M 19.92M 260M 20.11M 19.67M 825M | P/E 2026 * |
-1.45x | P/E 2027 * | -2.52x |
|---|---|---|---|---|---|
| Enterprise Value | 5.36M 4.61M 4.35M 3.96M 7.4M 512M 7.47M 51.76M 19.92M 260M 20.11M 19.67M 825M | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.19x |
| Free-Float |
90% | Yield 2026 * |
-
| Yield 2027 * | - |
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| YCBD | Delayed | |
CBOE
| YCBD | Real-time |
Last Transcript : cbdMD, Inc.
| 1 day | -2.83% | ||
| 1 week | -0.62% | ||
| Current month | -2.45% | ||
| 1 month | -15.55% | ||
| 3 months | -30.92% | ||
| 6 months | -28.68% | ||
| Current year | -64.59% |
| 1 week | 0.47 | 0.5 | |
| 1 month | 0.45 | 0.62 | |
| Current year | 0.45 | 1.34 | |
| 1 year | 0.45 | 2.56 | |
| 3 years | 0.45 | 13.84 | |
| 5 years | 0.45 | 820.8 | |
| 10 years | 0.45 | 2,606.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
T. Kennedy
CEO | Chief Executive Officer | 47 | 01/03/2023 |
Zeb Booker
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2019 |
Sibyl Swift
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bakari Sellers
BRD | Director/Board Member | 41 | 01/03/2017 |
William Raines
BRD | Director/Board Member | 66 | 19/04/2019 |
Scott Stephen
CHM | Chairman | 60 | 03/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/4/26 | Free | Director | 1,572 | 0.0150% | ||
| 14/4/26 | Free | Director | 1,572 | 0.0150% | ||
| 14/4/26 | Free | Director | 1,572 | 0.0150% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.83% | -0.62% | -29.92% | -95.37% | 5.36M | ||
| -0.11% | -3.16% | +48.82% | +91.49% | 1,001B | ||
| -0.27% | -4.34% | +51.52% | +65.89% | 642B | ||
| +1.63% | -2.00% | +20.49% | +71.12% | 451B | ||
| +0.35% | -2.89% | +29.17% | +36.55% | 340B | ||
| +0.69% | -12.78% | +11.04% | +27.98% | 263B | ||
| +0.78% | -1.18% | -0.77% | +12.97% | 247B | ||
| -2.25% | -13.88% | +37.33% | +47.43% | 207B | ||
| -2.10% | -6.41% | -19.12% | -59.09% | 197B | ||
| -0.58% | -4.24% | +25.65% | +90.54% | 180B | ||
| Average | -0.00% | -5.04% | +17.42% | +28.95% | 352.63B | |
| Weighted average by Cap. | +0.38% | -4.65% | +31.86% | +57.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.92M 18.85M 17.79M 16.21M 30.29M 2.1B 30.57M 212M 81.54M 1.06B 82.33M 80.53M 3.38B | 28.6M 24.59M 23.2M 21.14M 39.51M 2.73B 39.87M 276M 106M 1.39B 107M 105M 4.4B |
| Net income | -3.33M -2.87M -2.7M -2.46M -4.6M -319M -4.65M -32.2M -12.39M -162M -12.51M -12.24M -513M | -4.95M -4.25M -4.01M -3.66M -6.83M -473M -6.9M -47.8M -18.4M -240M -18.57M -18.17M -762M |
| Net Debt | - | - |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | USD 0.4780 | -2.83% | 71,617 |
| 09/09/26 | USD 0.4919 | -1.56% | 71,766 |
| 08/09/26 | USD 0.4997 | +5.07% | 34,356 |
| 04/09/26 | USD 0.4756 | -1.12% | 83,692 |
| 03/09/26 | USD 0.4810 | -3.76% | 358,746 |
Sell
Buy

Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.4780
Average target price
-
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YCBD Stock
Select your edition
All financial news and data tailored to specific country editions

















